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Abstract
Background: A family history, reflecting genetic susceptibility as well as shared environmental and behavioral factors, 
is an important risk factor for common chronic multifactorial diseases such as cardiovascular diseases, type 2 diabetes 
and many cancers.
Discussion: The purpose of the present paper is to discuss the evidence for the use of family history as a tool for 
primary prevention of common chronic diseases, in particular for tailored interventions aimed at promoting healthy 
lifestyles. The following questions are addressed: (1) What is the value of family history information as a determinant of 
personal disease risk?; (2)How can family history information be used to motivate at-risk individuals to adopt and 
maintain healthy lifestyles in order to prevent disease?; and (3) What additional studies are needed to assess the 
potential value of family history information as a tool to promote a healthy lifestyle?
Summary: In addition to risk assessment, family history information can be used to personalize health messages, 
which are potentially more effective in promoting healthy lifestyles than standardized health messages. More research 
is needed on the evidence for the effectiveness of such a tool.
Background
Clinical trial evidence shows that lifestyle modifications
(e.g. weight loss, eating more healthily, increased physical
activity and smoking cessation) can reduce the incidence
of cardiovascular diseases [1], type 2 diabetes [2,3] and
s o m e  t y p e s  o f  c a n c e r s  [ 4 ] .  H o w e v e r ,  i t  h a s  b e c o m e
increasingly clear that general health education programs
aimed at the whole population have limited effect [5].
One way of increasing the effectiveness of these programs
is to target interventions at individuals who are at
increased risk of developing these diseases.
Most common chronic diseases are multifactorial in
nature, resulting from interactions of genetic susceptibil-
ity, and behavioral and environmental influences. Suscep-
tibility genes for common chronic diseases are newly
discovered each day and advances in screening technol-
ogy make it possible to screen large populations for mul-
tiple susceptibility genes [6]. Currently, several
commercial companies, mostly in the US, already offer
genetic profiling to the public (for an overview, see [7]).
These companies claim that genetic profiling can provide
accurate information about a person's susceptibility to a
range of diseases. They suggest that genetic profiling can
support decisions concerning preventive actions, includ-
ing lifestyle choices [8]. However, for most genes included
in the commercial profiles, the evidence for significant
gene-disease associations is insufficient [9]. Hence, these
tests currently have limited value in predicting disease
risk and for developing personalized prevention mes-
sages.
Another important source of risk information to which
most people have access is the health status of their close
relatives (family history). Compared to genetic profiling,
family history information has the advantage that it not
only reflects the consequences of multiple genetic factors,
but also captures the complex interactions between
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genetic, environmental, and behavioral factors, and may
therefore be a better determinant of disease risk than
genetic profiling. Epidemiological studies show that a
family history is a strong and independent risk factor for
cardiovascular diseases [10,11], type 2 diabetes [12], and
many cancers [13-16]. In the clinical genetics setting, the
value of systematically collecting and interpreting
detailed family history information has long been recog-
nized, i.e. for early diagnosis, decisions on genetic testing,
and reproductive choices [17,18]. In primary care, the
collection of family history information has been mainly
used for diagnostic purposes in patients exhibiting dis-
ease symptoms, referrals for specialist evaluation (e.g. in
the case of a suspected Mendelian disorder), and as a psy-
chosocial tool to gain insight into family dynamics [19]. It
has been suggested that the systematic collection and
interpretation of family history may also be used as a tool
for the prevention of common chronic diseases [20]. This
information could not only be used to identify individuals
at increased disease risk but also to raise risk awareness
and motivate people to engage in risk-reducing behav-
iors. There is some evidence for the effectiveness of can-
cer screening on behavior following family history risk
assessment [21,22]. However, only a few studies have
examined the effectiveness of the use of family history
information as a tool to promote a healthy lifestyle for
primary disease prevention [23-26]. The purpose of the
present paper is to discuss the evidence for the use of
family history as a tool for primary prevention of com-
mon chronic diseases, such as cardiovascular disease, in
particular for tailored interventions aimed at promoting
healthy lifestyles. The following questions are addressed:
(1) What is the value of family history information as a
determinant of personal disease risk?; (2)How can family
history information be used to motivate at-risk individu-
als to adopt and maintain healthy lifestyles in order to
prevent disease?; and (3) What additional studies are
needed to assess the potential value of family history
information as a tool to promote a healthy lifestyle?
Discussion
What is the value of family history information as a 
determinant of personal disease risk?
In order to determine personal disease risk, clear meth-
ods to assess the risk associated with a given family his-
tory are required. To this end, epidemiological data need
to be translated to individual risk. Several methods have
been developed to facilitate interpretation of family his-
tory information. A comprehensive risk assessment tool
that categorizes individuals into risk strata (e.g. low-,
moderate- and high risk) based on family history, has
been developed by Scheuner et al. [27]. To stratify indi-
viduals into risk groups, detailed information is collected
about the number of affected family members, kinship
and age of onset of a specific disease. Such tools have
been developed for several multifactorial diseases. For
example, as part of a public health initiative, the Centers
for Disease Control and Prevention (CDC) developed an
interactive multi-generational web-based tool to assess
familial risk for six diseases (coronary heart disease,
stroke, diabetes, and colorectal, breast, and ovarian can-
cer) [26]. Recently, three systematic reviews evaluating
family history collection tools for clinical use have been
published [28-30].
Besides risk stratification based on family history, this
information can also be incorporated into a multifactorial
risk assessment tool that includes other risk factors such
as cholesterol levels and overweight. Examples include
the QDScore, an algorithm to calculate diabetes risk [31],
and the Reynolds Risk Score for cardiovascular disease
risk assessment [32]. Family history information is gener-
ally assessed with a single yes or no question, asking if any
one of the first degree family members has the disease. To
each factor associated with the disease, appropriate
weights, based on sound epidemiological evidence, are
assigned. This multifactorial risk assessment approach
has also been incorporated into several guidelines, for
example European guidelines on diabetes, pre-diabetes,
and cardiovascular disease [33].
In order to use family history information as a determi-
nant of an individual's disease risk, the accuracy of self-
reported family history should be ascertained. Studies
show that for breast, colorectal and prostate cancers
[16,34], as well as for cardiovascular diseases [35,36], rela-
tives report with a reasonable degree of accuracy on the
disease status of their close family members. The family
history of other common chronic diseases, such as type 2
diabetes [37] and ovarian cancer [16,34], and less close
family members (second degree relatives) are often
reported with a lower degree of accuracy. The accuracy of
self-reports is restricted by awareness and understanding
of a condition in a family member. Cultural variation in
how family is conceptualized can also affect the accuracy
[38]. For example, in many cultures individuals place
greater importance on, and have greater knowledge
about, one side of the family. Raising public awareness of
the importance of family history of cardiovascular dis-
eases, type 2 diabetes and specific types of cancers (e.g.
by mass-media campaigns) is likely toincrease the accu-
racy of self-reporting of family history information.
Assuming that it is possible to collect fairly accurate
information about a person's family history, more studies
are needed to establish how this information should be
interpreted to determine a person's disease risk, and by
which methods for translating this information into indi-
vidual risk assessment are most useful.Claassen et al. BMC Public Health 2010, 10:248
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How can family history information be used to motivate at-
risk individuals to adopt and maintain healthy lifestyles in 
order to prevent disease?
Individuals who are at higher than average or population
risk can be offered interventions to reduce or manage dis-
ease risk. In addition to medical recommendations, such
as genetic testing, early screening (e.g. mammography)
and medication, interventions may be aimed at promot-
ing a healthy lifestyle. Often such interventions incorpo-
rate standard health messages (such as lose weight, eat
more healthily, be more active, and stop smoking). How-
ever, the effectiveness of providing individuals who are at
higher risk with these type of health messages is limited
[5]. Individualized messages tailored to specific charac-
teristics and knowledge of individuals with an increased
risk can be more persuasive than standardized ("one-size
fits all") messages [5,39,40].
The identification of health and illness beliefs that con-
tribute to an individual's perception of disease risk may
help to determine the key elements for tailoring individu-
alized health messages. Most people with a family history
have at least some relevant beliefs and knowledge about
their disease risk. According to the Common Sense
Model of the self-regulation of health and illness, these
fragmentary beliefs are assembled into a mental model of
personal disease risk (or illness representations), which
people use in interpreting information [41,42]. Illness
representations of people with a family history of a com-
mon disease can conflict with the epidemiological risk
models of health professionals [43,44]. While lay under-
standing of personal disease risk may be based upon fac-
tors similar to epidemiological knowledge-such as the
number of affected relatives, their age at diagnosis, and
the level of kinship-other important factors have also
been identified [44-50]. These include the experience of a
relative's illness, feelings of closeness to the affected rela-
tive, and perceived differences between themselves and
the affected relative (e.g. gender, age, personality, lifestyle
and physical characteristics). Illness representations
include beliefs about disease causation and controllabil-
ity, in particular the influence of genetic and behavioral
factors. Often people are not aware that their family his-
tory places them at risk. The role of behavioral factors
may also be misunderstood. People not only tend to
underestimate energy intake and overestimate physical
activity [51] but also underestimate the potential conse-
quences of maintaining their current lifestyle, and have
little knowledge about preventive options [46]. Conse-
quently, people may not be aware of a potential health
problem and therefore may not see a need to change.
Prevention programs may be more likely to succeed if
they incorporate an exploration of individual pre-existing
illness representations alongside epidemiological risk fac-
tors [52]. Since health messages can be tailored to key ele-
ments of people's illness representations, one of the main
challenges is to develop messages that fit within people's
illness representations [53]. These messages should not
only inform people about their disease risk based on what
people already know and particularly addressing errone-
ous beliefs and gaps in knowledge, but should also moti-
vate them to change their lifestyle.
To inform people about their disease risk, it is impor-
tant that people receive objective and clear feedback on
the risk associated with their family history and other risk
factors. Often, risk information is communicated using
verbal (e.g. high vs. low risk), numerical (frequencies and
percentages), or visual (e.g. bar charts and icons) formats.
These formats influence the effects on risk perception
and subsequent behavior [54-59]. Besides probability
information, people need to receive information about
the nature of the risk (causes, consequences and severity)
[55], because this information may make people more
aware of the consequences of maintaining their current
lifestyle, and broaden their illness representations to
incorporate a multi-causal explanation of disease risk.
Subsequently, individualized prevention messages can be
offered that match these explanations, thereby increasing
people's confidence in the effectiveness of specific pre-
vention options [42]. For example, providing smokers
with a family history of cardiovascular disease with an
explanation of how smoking increases their risk may
strengthen their confidence in the effectiveness of smok-
ing cessation in reducing their risk for cardiovascular dis-
ease.
There is conflicting evidence about whether being a
member of a family with affected relatives already has a
positive effect on motivation to adopt a healthy lifestyle
[60-62]. Few studies have assessed the effectiveness of
using family history information as a tool to communi-
cate disease risk and to motivate at-risk individuals to
change lifestyles and maintain healthy ones. One study
evaluating the use of a family history assessment tool
reported increases in yearly medical examinations and
b l o o d  p r e s s u r e  c h e c k s  i n  b o t h  h i g h -  a n d  a v e r a g e - r i s k
families but did not report on lifestyle modifications [23].
According to a cross-sectional study, people who were
informed of their familial risk of diabetes (by their doc-
tors) reported greater awareness of risk and lifestyle
changes to reduce risk, such as diet and exercise, than
those who were not informed of their familial risk [24]. In
a randomized controlled trial among high-risk individu-
als with a positive family history of type 2 diabetes, par-
ticipants who had received additional information on
familial risk reported more personal control over pre-
venting diabetes and also reported more healthy eating
habits than those who did not receive the additional
information [25]. A large clinical trial assessing the clini-
cal utility of a family history tool developed by the CDC isClaassen et al. BMC Public Health 2010, 10:248
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currently being evaluated [26]. In this multicenter trial,
the effects of the provision of both familial risk assess-
ment and prevention messages on risk perceptions, dis-
ease-related attitudes and beliefs, as well as change in
health behaviors on members of primary care practices in
the U.S. are examined.
What additional studies are needed to assess the potential 
value of family history information as a tool to promote a 
healthy lifestyle?
A research agenda to evaluate the use of family history
information in the prevention of common chronic dis-
eases is currently being carried out in many governmen-
tal and academic institutions in the U.S. and elsewhere.
This agenda addresses the key elements for assessing the
added value of family history information, including the
validity and interpretation of the information collected,
and the practical barriers to implementation (see also
[63,64] for an overview of specific research questions).
However, this agenda does not specifically address how
family history information can be used to motivate peo-
ple to adopt and maintain a healthier lifestyle. To address
the questions that were raised in this discussion, the
research agenda should be refined and/or expanded.
In order to develop more effective personalized health
messages that fit within people's mental model of disease
risk, further research is needed into their pre-existing ill-
ness representations. In addition to qualitative studies,
which can provide insight into the content of lay beliefs
about personal disease risk, quantitative studies are
needed to assess how these beliefs are assembled into a
mental model and how they affect preventive behavior,
for example how beliefs about family history and disease
causation are linked to beliefs about the effectiveness of
p r e v e n t i v e  o p t i o n s .  M o r e  s t u d i e s  a r e  a l s o  n e e d e d  t o
assess whether and how these beliefs differ across indi-
viduals. Prior research has shown that beliefs vary across
diseases and gender [65-67], but little is known about cul-
tural and ethnic diversity and the effects of educational
level [49].
In order to motivate people to adopt a healthier life-
style, it may be possible to build on interventions that
already have proven successful in changing lifestyle in
high-risk individuals [1-4], such as in an extended follow-
up study evaluating the effects of individualized counsel-
ing on lifestyle goals, such a s  r e d u c i n g  w e i g h t  a n d
increasing physical activity, in people at risk for diabetes
[3]. Further research is needed to explore the effective-
ness of differentiation of health messages based on family
history information (high vs. low familial risk), other risk
factor information, and to identify the components of the
intervention that are most effective in achieving perma-
nent lifestyle changes. It should also be noted that
although providing information is usually a necessary
prerequisite for behavior change, it is rarely sufficient to
promote change. When designing interventions other
determinants, such as the social and physical environ-
ment, need to be considered.
In addition, more knowledge is needed about the best
mode of delivery of family history risk information. Phy-
sicians have reported time restrictions, lack of reimburse-
ment, and the complexity of familial risk interpretation as
barriers to the routine and systematic collection and use
of family history for disease prevention [68]. Decision
support systems and computer-aided tools that can be
self-administered or administered by a nurse practitioner
or physician assistant might reduce some of these barri-
ers. In addition, internet-based interventions have the
potential to reach more people at lower costs. However,
they lack the social support that individuals receive from
interpersonal counseling, while disparities in computer
skills, internet access and public concerns about internet
security may affect response.
Finally, there is the possibility that knowledge of family
history will have adverse psychological effects. Some
experts consider that informing people about an
increased risk based on their family history could induce
a sense of fatalism-the belief that little can be done to
change the risk-which can decrease motivation to change
behavior [53,69,70]. The family history risk information
may also evoke anxiety, which can induce maladaptive
responses, such as avoidance or denial of the presented
information [71]. False reassurance, either because a per-
son has no family history or does not identify with the
affected relative, is another potential adverse effect that
needs careful examination [72]. So far, in studies where
familial risk was discussed with people who had a family
history of diabetes [25,73,74] and colorectal cancer
[75,76] no (long term) adverse psychological effects were
n o t e d .  T h i s  i s  i n  l i n e  wi t h  t h e  l a r g e r  l i t e r a t u r e  o n  t h e
emotional impact of a wide range of health risk assess-
ments (see review by Shaw et al. [77]).
Summary
Detailed family history information can be used-along
with personal risk factors such as weight and smoking
status-as a simple, easily applied and cost-effective tool to
determine a person's disease risk. In addition to risk
assessment, family history information can also be used
to personalize health messages, which may be more effec-
tive in motivating people to adopt and maintain a health
lifestyle than standardized health messages. A personal-
ized health message should be phrased in such a way that
it fits within the target's pre-existing beliefs about current
health status, possible causes and risk factors, age of
onset and course of the disease, magnitude of and poten-
tial consequences of the risk, and ways to reduce the risk.
In this way, personalized risk information can correctClaassen et al. BMC Public Health 2010, 10:248
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erroneous beliefs, fill knowledge gaps, and reinforce peo-
ple's confidence in their ability to change behavior. The
evidence for the effectiveness of using family history
information as a personalized tool for disease prevention,
in particular for raising motivation to adopt and maintain
a healthy lifestyle, is very limited. More research is
needed before a definite answer can be given to the ques-
tion of whether and how family history information
should be used and promoted as a tool to motivate people
to change their behavior.
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